Artrya Limited CEO John Barrington talks to Proactive about the Perth, Australia-based artificial intelligence medical technology company's appointment of Dr. Jacque Sokolov as Chair of Artrya’s Clinical Advisory Board. Barrington says Dr. Sokolov will help lead the group's US clinical research program for its coronary heart disease diagnosis technology. He adds that Dr. Sokolov is a prominent cardiologist clinical who has worked with more than 100 healthcare organizations in the US.
Artrya talks through its plan to bring its AI coronary heart disease diagnostic to the US
